Refine by
Depression Suppliers & Manufacturers
13 companies found
Technologybased inGwanak-ro, Gwanak-gu, SOUTH KOREA
KoBioLabs is recognized for its international level of technical skills by publishing a number of domestic and foreign patent papers in the fields of microbiome analysis, probiotics, and microbiome treatment technologies of various samples. In ...
Technologybased in, NETHERLANDS
At veriNOS Pharmaceuticals, we focus on the clinical development of a drug that specifically inhibits a defined cascade that is relevant and common in different disease settings. The activation of iNOS with subsequent excessive production of cell ...
Ronopterin – treatment to reduce peritumoral brain edema and improve patient outcomes. Adequate pharmacologic control of peritumoral edema in glioblastoma and brain metastases is still insufficient and is limited by side effects in more than ...
Technologybased inChester, UNITED KINGDOM
Byotrol's first antimicrobial technology was invented over 20 years ago, and since then we have developed a number of biocidal technologies and antimicrobial test methods, which challenge traditional disinfectant products and methods of cleaning, to ...
Technologybased inParis, FRANCE
Pixium Vision, created in December 2011, is a bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling ...
Treatment for blindness represents a major unmet medical need throughout the world, including Europe and the United States. In 2010, there were about 285 million visually impaired people worldwide and around 39 million were totally ...
Technologybased inWoburn, MASSACHUSETTS (USA)
We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and ...
Aphios utilized its patented SuperFluids™ fractionation and manufacturing technologies to develop Xantol™. Aphios is developing Xantol™ for mild to moderate depression, as a natural alternative to prescription ...
Technologybased inBrooklyn, NEW YORK (USA)
Synchron, an endovascular brain interface company, is a leader in implantable neural interface technology. The clinical-stage company is developing a neuroprosthesis for the treatment of paralysis and the first endovascular implantable ...
Technologybased inWoburn, MASSACHUSETTS (USA)
Aegle Therapeutics is a first in class, phase 1/2a stage biotechnology company isolating extracellular vesicles including exosomes (EVs) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa ...
Thermal injury is one of the most common and devastating forms of trauma, as it affects the skin, the largest and most visible organ. According to the CDC, about 1.1 million people suffer a burn injury and seek medical help every year in the U.S. Of ...
Technologybased inKailua-Kona, HAWAII (USA)
Cellana, a leading developer of algae-based bioproducts, uses the most productive plants on earth – marine microalgae – to produce its ReNew line of Omega-3 EPA and DHA oils, animal feed, and biofuel feedstocks. Cellana’s patented ALDUO system, a ...
Cellana’s Marine Algae Produce Healthy Nutritional Oils That Contain an Abundance of Omega-3s. Algae found in the sea are a major source of Polyunsaturated Fatty Acids (PUFAs), such as Omega-3s, which are essential for good health. These ...
Technologybased inHerzliya, ISRAEL
elminda was founded in 2006 with the goal of addressing the unmet needs of people suffering from brain related disorders. Our mission: perfect a technology that would reveal an individual’s unique brain function “signatures” or “fingerprints,” ...
Technologybased inYongin-si, SOUTH KOREA
Vivozon is a global innovative drug development company established in 2008. We built an efficacy-based new drug discovery system that is clearly distinct from the existing new drug development paradigm, and discovered the non- narcotic analgesic ...
VVZ-2471 is a new drug candidate for treating chronic pain including neuropathic pain. Recently, the prevention and treatment potential of drug (morphine) addiction, anxiety, and depression have also been demonstrated through ...
Technologybased inCoral Gables, FLORIDA (USA)
We are a late-stage biotech company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Our experienced and dedicated team is committed to making a difference in the lives of patients and their ...
REL-1017 is a novel N-methyl-D-aspartate receptor (NMDAR) channel blocker in phase 3 clinical trials for the treatment of Major Depressive Disorder (MDD). REL-1017 works with a MOA markedly different from standard serotoninergic ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most cancer vaccines have failed to ...
Technologybased inLexington, KENTUCKY (USA)
TruDiagnostic is leading the way in epigenetic science. TruAge test is the best at-home kit for anti-aging enthusiasts who want a comprehensive look at their baseline aging metrics, as well as in-depth analysis of specific, age-related biomarkers. ...
The TruAge Complete test by TruDiagnostic offers an advanced analysis of biological aging using state-of-the-art algorithms developed in conjunction with leading institutions like Harvard University and Yale University. The test measures various ...